Clinical outcome of Epstein–Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of malignant lymphoma. The incidence of Epstein–Barr virus (EBV)-positive DLBCL in Asian and Latin American countries ranges from 8 to 10%. The prognosis of patients with EBV-positive DLBCL is controversial. To compare the clinical out...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Sato, Ai, Nakamura, Naoya, Kojima, Minoru, Ohmachi, Ken, Carreras, Joaquim, Kikuti, Yara Yukie, Numata, Hiroki, Ohgiya, Daisuke, Tazume, Kei, Amaki, Jun, Moriuchi, Makiko, Miyamoto, Mitsuki, Aoyama, Yasuyuki, Kawai, Hidetsugu, Ichiki, Akifumi, Hara, Ryujiro, Kawada, Hiroshi, Ogawa, Yoshiaki, Ando, Kiyoshi
Format: Artigo
Idioma:Inglês
Publicat: BlackWell Publishing Ltd 2014
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4462402/
https://ncbi.nlm.nih.gov/pubmed/24974976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12467
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars